Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Camila B. Xavier"'
Autor:
Camila B. Xavier, Felipe S.N.A. Canedo, Fabíola A.S. Lima, Raíssa R. Melo, Luiz Guilherme C.A. Lima, José Flávio G. Marin, Ciro E. Souza, Olavo Feher
Publikováno v:
Current Problems in Cancer: Case Reports, Vol 4, Iss , Pp 100117- (2021)
Inflammatory myofibroblastic tumor (IMT) is a rare entity that affects mostly children and young adults. The lungs are the most frequent primary site. When feasible, surgical resection is the standard of care and it is associated with long-term survi
Externí odkaz:
https://doaj.org/article/bb59d42a73c0450c93b1f7c0d0779bb6
Autor:
Camila B Xavier, Rudinei Link, Leonília Abreu, Fabiana Bettoni, Fabiane Marson, Pedro A F Galante, Cibele Masotti, Mariane T Amano, Vinicius de Molla, Anamaria A Camargo, Paula F Asprino, Jorge Sabbaga
Publikováno v:
The Oncologist.
Objective Li-Fraumeni syndrome (LFS) is a pan-cancer predisposition syndrome caused by germline pathogenic variants in the gene TP53. The interpretation of TP53 variants in clinical scenarios outside the classic LFS criteria may be challenging. Here,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::deff588dff63236232faa00ed48344e6
https://doi.org/10.1093/oncolo/oyad105
https://doi.org/10.1093/oncolo/oyad105
Autor:
Nildevande F. Lima, Luana A.F. Sampaio, Camila B. Xavier, Romulo L. Mattedi, Marcelo A. Queiroz, Willian C. Nahas, Denis L. Jardim
Publikováno v:
JCO Precision Oncology.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a94775cebbe29e3f8cf3072d141c3a8e
https://doi.org/10.1200/po.22.00414
https://doi.org/10.1200/po.22.00414
Autor:
Camila B. Xavier, Carlos Diego H. Lopes, Beatriz M. Awni, Eduardo F. Campos, João Pedro B. Alves, Anamaria A. Camargo, Gabriela D. A. Guardia, Pedro A. F. Galante, Denis L. Jardim
Publikováno v:
Cancers. 14(21)
Purpose: Solid tumors harboring tumor mutational burden (TMB) ≥10 mutations per megabase (mut/Mb) received agnostic approval for pembrolizumab. This work aims to analyze the somatic mutational profile’s influence on the outcomes of patients with
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::18e9c9d500ded73908c7eebaefa54915
https://pubmed.ncbi.nlm.nih.gov/36358851
https://pubmed.ncbi.nlm.nih.gov/36358851
Autor:
Camila B. Xavier, Carlos Diego H. Lopes, Beatriz M. Awni, Eduardo F. Campos, João Pedro B. Alves, Anamaria A. Camargo, Gabriela D. A. Guardia, Pedro A. F. Galante, Denis L. Jardim
PurposeSolid tumors harboring tumor mutational burden (TMB) ≥ 10 mutations per megabase (mut/Mb) received agnostic approval for pembrolizumab. However, TMB cut-off alone is not a predictor of overall survival (OS). This work aims to analyze the som
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c973dd1f91ebe2ace6e9c061dab20369
https://doi.org/10.1101/2022.04.10.22273664
https://doi.org/10.1101/2022.04.10.22273664
Autor:
Xavier, Camila B.1 (AUTHOR), Lopes, Carlos Diego H.1 (AUTHOR), Awni, Beatriz M.1 (AUTHOR), Campos, Eduardo F.1 (AUTHOR), Alves, João Pedro B.2 (AUTHOR), Camargo, Anamaria A.3 (AUTHOR), Guardia, Gabriela D. A.3 (AUTHOR), Galante, Pedro A. F.3 (AUTHOR), Jardim, Denis L.1 (AUTHOR) jardimde@gmail.com
Publikováno v:
Cancers. Nov2022, Vol. 14 Issue 21, p5433. 9p.
Autor:
Xavier, Camila B, Link, Rudinei, Abreu, Leonília, Bettoni, Fabiana, Marson, Fabiane, Galante, Pedro A F, Masotti, Cibele, Amano, Mariane T, Molla, Vinicius de, Camargo, Anamaria A, Asprino, Paula F, Sabbaga, Jorge
Publikováno v:
Oncologist; Jul2023, Vol. 28 Issue 7, p624-627, 4p, 1 Chart, 2 Graphs